Computer-based analyses of CT scans may help predict disease progression and track treatment response among people with PPF, per trial data.

Columnist Sam Kirton's birthday prompts reflection on his IPF and transplant journey. Like Phil Collins, he says, "Take a look at me now." ...

Lower activity of a gene called ZNF331 may help identify obstructive sleep apnea in people with idiopathic pulmonary fibrosis, per a study.

Suspecting that deconditioning might be contributing to his muscle soreness, columnist Kylene Henderson's husband, Donnie, is ...

Share this page with email Share this page on Facebook Share this page on X Share this page on Reddit Print Preferred Source on Google As my regular readers may remember, I am prescribed supplemental ...

The U.S. Food and Drug Administration (FDA) will decide by early next year whether or not to expand its approval of nebulized Tyvaso (treprostinil) — an inhaled treatment for people with certain lung ...

September is Pulmonary Fibrosis Awareness Month, and advocates around the globe are joining together to shine a light on what it means to live with pulmonary fibrosis (PF), a condition characterized ...

A new type of pericyte called Peri2 is linked to scar tissue formation in the lungs of people with pulmonary fibrosis (PF), according to a study. Pericytes are cells that surround blood vessels. A ...

According to its U.S. developer, the first of two global clinical trials designed to test Haduvio (nalbuphine extended-release) — a potential treatment for chronic cough due to idiopathic pulmonary ...

The inhaled therapy MNKD-201 was tolerated well in people with idiopathic pulmonary fibrosis (IPF) in a Phase 1 clinical trial, and a Phase 2 study to further test it is underway, the treatment’s ...

The oral therapy Jascayd (nerandomilast) has been approved in the European Union for adults with idiopathic pulmonary fibrosis (IPF) and progressive pulmonary fibrosis (PPF). The marketing ...

The Pulmonary Fibrosis Foundation (PFF), an advocacy group dedicated to advancing care for people with pulmonary fibrosis, has added two new members to its board of directors. Both new board members ...